University of Florida College of Pharmacy

Dr. Larisa Cavallari joined WJXT4 The Local Station / News4JAX this morning to discuss a new clinical trial focused on chronic acid reflux. Partnering with Dr. Ruchir Puri of UF Health Jacksonville, the research team will examine whether genotype-guided dosing of proton pump inhibitors, or PPIs, can improve treatment outcomes for patients with erosive esophagitis.

University of Florida trial on treating acid reflux Dr. Larisa Cavallari, professor in the UF College of Pharmacy, and Dr. Ruchir Puri, professor of surgery, join us to discuss UF Health Jacksonville's test trials on acid reflux treatment.

Our Young Alumni Council is seeking applicants for 2026-27! Alumni who graduated within the past 15 years are eligible to apply, with applications due July 15.

🔗 More information: https://go.ufl.edu/7s5iyut

As another year of the Gator Pharmacy Exploration Camp comes to a close, we bid farewell to the rising high school stars from around the state who spent the week at the University of Florida learning about pharmacy!

Join us this summer in Orlando for the UF College of Pharmacy’s Gator Receptions! Connect with alumni, faculty, students and friends of the college during the Florida Pharmacy Association Annual Meeting on July 17, and the FSHP - Florida Society of Health-System Pharmacists, Inc. Annual Meeting on Aug. 7. Light hors d’oeuvres and drinks will be provided.

RSVP today to reserve your spot!

FPA Reception: https://app.smartsheet.com/b/form/019c902295a47dd8a29c88f4bd483fd8

FSHP Reception: https://app.smartsheet.com/b/form/019c961709097c9eb39d89cd4cae80b9

What if your genes could determine the best treatment for chronic acid reflux? Researchers at UF Health Jacksonville and the UF College of Pharmacy are launching the first clinical trial to explore whether genotype-guided dosing of proton pump inhibitor medications can improve treatment outcomes for erosive esophagitis.

UF Health Jacksonville trial explores DNA-guided treatment for acid reflux » College of Pharmacy » University of Florida The study involving UF College of Pharmacy researchers will be the first to examine whether genotype-guided dosing of proton pump inhibitor medications can improve treatment outcomes for erosive esophagitis.

The UF College of Pharmacy’s Gator Pharmacy Exploration Camp is celebrating its fifth year by welcoming 29 rising high school seniors for an immersive week of pharmacy and health care experiences. The campers started their week with CPR training, simulation center activities and team-building exercises.

A delegation from the UF College of Pharmacy recently visited Taiwan to advance new partnerships with National Taiwan University and the National Defense Medical University College of Pharmacy. In the past year, these institutions have formalized their relationships with UF through a Memorandum of Understanding and an Agreement of Academic Collaboration that will promote joint research initiatives, scholarly publications, conferences and academic programming. During the visit, UF faculty delivered lectures to pharmacy students, toured community pharmacies and research facilities and gained insight into Taiwan’s culture and pharmacy practice.

Congratulations to UF College of Pharmacy graduate Rebecca Goldfaden, Pharm.D., '11,on being named to UF's 40 Gators Under 40 class of 2026!

Read more: https://go.ufl.edu/ipwzwm3

Citing research led by faculty in the UF College of Pharmacy, the National Institutes of Health has announced its Investigational New Drug application for mitragynine, the primary psychoactive compound found in kratom, has taken effect with the U.S. Food and Drug Administration. The milestone clears the way for an NIH-led phase I clinical trial in humans to evaluate mitragynine as a potential treatment of opioid use disorder.

UF College of Pharmacy researchers developed the purified formulation that will be used in the trial and conducted the preclinical studies that supported the Investigational New Drug application.

https://www.nih.gov/news-events/news-releases/nih-research-clears-way-study-experimental-treatment-opioid-use-disorder